Key result
Over a 4-hour period, human lipoprotein lipase and human hepatic lipase significantly reduced the platelet macroaggregatory response to collagen from 17.0 Ohms to 1.6 and 1.2 Ohms, respectively.
Why the study?
Does the in vitro addition of heparin-releasable lipolytic enzymes reduce platelet macroaggregation in whole blood from healthy volunteers?
Does the in vitro addition of heparin-releasable lipolytic enzymes reduce platelet macroaggregation in whole blood from healthy volunteers?
Heparin-induced lipolysis generates lipoprotein degradation products that inhibit platelet macroaggregation, providing a potential mechanism for the platelet dysfunction observed during cardiopulmonary bypass.
Answers are grounded in this paper and cite their sources.
Suggests mechanism for platelet dysfunction in cardiopulmonary bypass; hypothesis-generating and requires clinical confirmation.
Heparin, when administered to patients undergoing operations using cardiopulmonary bypass, induces plasma changes that gradually impair platelet macroaggregation, but heparinization of whole blood in vitro does not have this effect. The plasma changes induced by heparin in vivo continue to progress in whole blood ex vivo. Heparin releases several endothelial proteins, including lipoprotein lipase, hepatic lipase, platelet factor-4 and superoxide dismutase. These enzymes, which remain active in plasma ex vivo, may impair platelet macroaggregation after in vivo heparinization and during cardiopulmonary bypass. In the present study, proteins were added in vitro to hirudin (200 units.ml(-1))-anticoagulated blood from healthy volunteers, and the platelet macroaggregatory responses to ex vivo stimulation with collagen (0.6 microg.ml(-1)) were assessed by whole-blood impedance aggregometry. Over a 4 h period, human lipoprotein lipase and human hepatic lipase reduced the platelet macroaggregatory response from 17.0+/-2.3 to 1.5+/-1.3 and 1.2+/-0.6 Omega respectively (means+/-S.D.) (both P <0.01; n =6). Other lipoprotein lipases also impaired platelet macroaggregation, but platelet factor-4 and superoxide dismutase did not. Platelet macroaggregation showed an inverse linear correlation with plasma concentrations of non-esterified fatty acids ( r (2)=0.69; two-sided P <0.0001; n =8), suggesting that heparin-induced lipolysis inhibits platelet macroaggregation. Lipoprotein degradation products may cause this inhibition by interfering with eicosanoids and other lipid mediators of metabolism.
No takes yet. Share an insight, caveat, or question.
Muriithi et al. (2002) studied Healthy volunteers (n=34). Human lipoprotein lipase and human hepatic lipase vs. Baseline (time 0) was evaluated on Platelet macroaggregatory response to ex vivo stimulation with collagen (0.6 µg ml-1) at 4 hours (p=<0.01). Over a 4-hour period, human lipoprotein lipase and human hepatic lipase significantly reduced the platelet macroaggregatory response to collagen from 17.0 Ohms to 1.6 and 1.2 Ohms, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: